IRB Number:

112-05

Trial Status:

Inactive

Phase: IV

Why is this study being done?

This research study is being done to study the effects (good and bad) of measuring the amount of CellCept in your blood to determine your CellCept dose versus taking a fixed dose of CellCept, without measuring the amount in your blood. CellCept is one of the three immunosuppressant drugs (drugs that suppress your immune system), which you will take after your kidney transplant. You will also take cyclosporine or tacrolimus and corticosteroids.

Who is Eligible to Participate in the Study?

Participants must be between 18 and 70 years of age and should be receiving their first or second transplant from either a living or deceased donor. Participants will have some screening blood tests to see if they meet additional criteria.

Minimum Age:

18

Maximum Age:

75

What is Involved With this Study?

Participants will be put into one of the three groups. They will be asked to return throughout the 24 months for physcial exams, blood and urine tests.

How long will the Study run?

Participants will be enrolled in this research study for up to 24 months.

Who can I Contact for Additional Information on this Trial?

For more information or to participate in this research study, please contact Cindy Groettum at (507) 266-8725.

What is/are the Locations of this Clinical Trial?

• Rochester, MN

Last updated: 03/29/2006